The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
A Phase II Trial of Chemoradiotherapy for Stage I Esophageal Squamous Cell Carcinoma: Japan Clinical Oncology Group Study (JCOG9708)
Abstract
OBJECTIVE: The study objective was to evaluate the efficacy and toxicity of chemoradiotherapy with 5-fluorouracil (5-FU) plus cisplatin in patients with Stage I esophageal squamous cell carcinoma (ESCC). The primary endpoint was proportion of complete response (%CR). METHODS: Patients with Stage I (T1N0M0) ESCC, aged 20-75 years, without indication of endoscopic mucosal resection were eligible. Treatment consisted of cisplatin 70 mg/m(2) (day 1) and 5-FU 700 mg/m(2)/day (days 1-4) combined with 30 Gy radiotherapy (2 Gy/day, 5 days/week, days 1-21). The cycle was repeated twice with 1-week split. Salvage surgery was recommended for residual tumor or local recurrence. RESULTS: From December 1997 to June 2000, 72 patients were enrolled. No ineligible patient or major protocol violation was observed. There were 63 CRs for %CR of 87.5% [95% confidence interval (CI): 77.6-94.1]. Six patients with residual tumor successfully underwent esophagectomy. There was no Grade 4 toxicity. Four-year survival proportion was 80.5% (95% CI: 71.3-89.7), and 4-year major relapse-free survival proportion was 68% (95% CI: 57.3-78.8) (mucosal recurrence removed by endoscopy was not counted as an event). CONCLUSIONS: High CR proportion and survival proportion with mild toxicity suggest that this regimen could be considered as a candidate of new standard treatment to be compared with surgery in patients with Stage I ESCC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
TNM Classification of Malignant Tumours
(1987) · Springer eBooks · doi:10.1007/978-3-642-82982-6 · Cited by 16,049
Cancer: Principles and Practice of Oncology.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-819_4 · Cited by 8,516
Herskovic, A., Martz, K., Al-Sarraf, M., Leichman, L., Brindle, J., Vaitkevicius, V., Cooper, J., Byhardt, R., Davis, L., & Emami, B. (1992) · New England Journal of Medicine · doi:10.1056/nejm199206113262403 · Cited by 2,108
International Union against Cancer
(1959) · Journal of the Faculty of Radiologists · doi:10.1016/s0368-2242(59)80060-9 · Cited by 1,220
Definitive Chemoradiotherapy for T4 and/or M1 Lymph Node Squamous Cell Carcinoma of the Esophagus
Ohtsu, A., Boku, N., Muro, K., Chin, K., Muto, M., Yoshida, S., Satake, M., Ishikura, S., Ogino, T., Miyata, Y., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.9.2915 · Cited by 437
Self-citationSurgical Strategies in Esophageal Carcinoma With Emphasis on Radical Lymphadenectomy
LERUT, T., LEYN, P. D., COOSEMANS, W., RAEMDONCK, D. V., SCHEYS, I., & LESAFFRE, E. (1992) · Annals of Surgery · doi:10.1097/00000658-199211000-00010 · Cited by 311
Coia, L. R., Engstrom, P. F., Paul, A. R., Stafford, P. M., & Hanks, G. E. (1991) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(91)90134-p · Cited by 266
Toxicity Grading Criteria of the Japan Clinical Oncology Group
Tobinai, K., Kohno, A., Shimada, Y., Watanabe, T., Tamura, T., Takeyama, K., Narabayashi, M., Fukutomi, T., Kondo, H., Shimoyama, M., et al. (1993) · Japanese Journal of Clinical Oncology · doi:10.1093/oxfordjournals.jjco.a039642 · Cited by 168
Cited by
Pimentel-Nunes, P., Libânio, D., Bastiaansen, B. A. J., Bhandari, P., Bisschops, R., Bourke, M. J., Esposito, G., Lemmers, A., Maselli, R., Messmann, H., et al. (2022) · Endoscopy · doi:10.1055/a-1811-7025 · Cited by 808
Esophageal cancer practice guidelines 2017 edited by the Japan esophageal society: part 2
Kitagawa, Y., Uno, T., Oyama, T., Kato, K., Kato, H., Kawakubo, H., Kawamura, O., Kusano, M., Kuwano, H., Takeuchi, H., et al. (2019) · Esophagus · doi:10.1007/s10388-018-0642-8 · Cited by 569
Self-citationEsophageal cancer practice guidelines 2017 edited by the Japan Esophageal Society: part 1
Kitagawa, Y., Uno, T., Oyama, T., Kato, K., Kato, H., Kawakubo, H., Kawamura, O., Kusano, M., Kuwano, H., Takeuchi, H., et al. (2019) · Esophagus · doi:10.1007/s10388-018-0641-9 · Cited by 519
Self-citationEndoscopic submucosal dissection/endoscopic mucosal resection guidelines for esophageal cancer
Ishihara, R., Arima, M., Iizuka, T., Oyama, T., Katada, C., Kato, M., Goda, K., Goto, O., Tanaka, K., Yano, T., et al. (2020) · Digestive Endoscopy · doi:10.1111/den.13654 · Cited by 439
Recent progress in multidisciplinary treatment for patients with esophageal cancer
Watanabe, M., Otake, R., Kozuki, R., Toihata, T., Takahashi, K., Okamura, A., & Imamura, Y. (2020) · Surgery Today · doi:10.1007/s00595-019-01878-7 · Cited by 428
Metadata
- Authors
- Kato, H., Sato, A., Fukuda, H., Kagami, Y., Udagawa, H., Togo, A., Ando, N., Tanaka, O., Shinoda, M., Yamana, H., & Ishikura, S.
- Venue
- Japanese Journal of Clinical Oncology
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-06-23
- Volume
- 39
- Issue
- 10
- Pages
- 638-643
- ISSN
- 0368-2811 (ISSN-L)
- 1465-3621
- OpenAlex
- W2123181758
- Cited by
- 295
- References
- 8
- FWCI
- 12.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.